DFX Intelligence
Borrowers
23 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Industry as filed contains “Pharmaceuticals, Biotechnology & Life Sciences” (remove)
Start from
23 borrower groups
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Falcon Parent Holdings, Inc Life sciences | unattributed | 6 | at least $257M | 98c | n/a | Nov 6, 2031 | Dec 31, 2024 |
| Solvias AG Life sciences | unattributed | 2 | at least $149M | 112c | n/a | Feb 27, 2030 | Mar 31, 2025 |
| Pharmalogic Holdings Corp Life sciences | unattributed | 3 | at least $138M | 99c | 3 pts | Jun 21, 2030 | Jun 30, 2024 |
| I•••••••• C•••••• E••••••• S•• Life sciences | unattributed | 1 | at least $75.5M | 93c | n/a | Sep 1, 2028 | Dec 31, 2021 |
| N•••• H••••••••• H•••••• A• Life sciences | unattributed | 1 | at least $33.0M | 99c | n/a | Feb 1, 2030 | Sep 30, 2025 |
| L••• H•••••••• I•• Life sciences | unattributed | 20 | at least $32.3M | 99c | 1 pts | Feb 23, 2032 | Dec 31, 2021 |
| E••• P••••••••• I•• Life sciences | unattributed | 1 | at least $27.0M | 106c | n/a | Dec 17, 2027 | Jun 30, 2026 |
| J•••••• M•••••• C••••••••• Life sciences | unattributed | 1 | at least $25.0M | 106c | n/a | Jun 27, 2028 | Jun 30, 2026 |
| S••••• T••••••••• P•• Life sciences | unattributed | 1 | at least $25.0M | 104c | n/a | Sep 28, 2028 | Dec 31, 2025 |
| S••••••• P••••••••• I•• Life sciences | unattributed | 1 | at least $20.0M | 105c | n/a | Aug 31, 2030 | Jun 30, 2026 |
| A••••••• O••••• T••••••• I•• Life sciences | unattributed | 1 | at least $19.5M | 106c | n/a | Feb 15, 2029 | Jun 30, 2026 |
| B••••••••• Life sciences | unattributed | 1 | at least $16.8M | 88c | n/a | Dec 31, 2028 | Dec 31, 2022 |
| W•• G•••• H•••••••• L•• Life sciences | unattributed | 2 | at least $15.7M | 101c | 0 pts | Dec 31, 2029 | Dec 31, 2023 |
| N••••• L••••••••• I•• Life sciences | unattributed | 1 | at least $8.5M | 104c | n/a | Apr 14, 2027 | Jun 30, 2026 |
| E•••• M•••• B•• Life sciences · grade B | unattributed | 1 | at least $7.7M | 62c | n/a | Jul 31, 2029 | Dec 31, 2022 |
| N•••••••• L•• Life sciences | unattributed | 1 | at least $6.1M | 95c | n/a | May 15, 2027 | Jun 30, 2026 |
| G•••••• B••••••••• I•• Life sciences | unattributed | 1 | at least $5.6M | 105c | n/a | Sep 13, 2027 | Jun 30, 2026 |
| i•••• P••••••••• P•• L•••••• Life sciences | Sponsor not establishedpossible: P•••••• E••••• P••••••• P•• L•••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $3.9M | 100c | n/a | Nov 1, 2031 | Dec 31, 2022 |
| C• B••••••••• L•• Life sciences | unattributed | 1 | at least $43,621 | 101c | n/a | Mar 21, 2030 | Sep 30, 2025 |
| I••••• V•••••• I•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Jun 30, 2026 |
| M•••••• B••• I•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Dec 31, 2022 |
| S••••••• P••••• Life sciences | unattributed | 2 | unknown | n/a | n/a | unstated | Mar 31, 2025 |
| Z•••• T••••••••• I•• Life sciences | unattributed | 1 | unknown | n/a | n/a | unstated | Jun 30, 2026 |
Page 1 of 1
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.